Latest Valuation News

WT Financial Group (ASX, WTL) reported a 20.5% rise in FY2025 net profit after tax to $4.6 million, driven by strong revenue growth and operational leverage. The company declared a fully-franked dividend of 0.7 cents per share, underpinned by its expanding B2B financial advice network and proprietary risk management framework.

Rapid Critical Metals has initiated a 2,000m diamond drilling campaign at its Webbs Silver Project in NSW, aiming to upgrade its resource to 2025 JORC standards and explore new high-potential silver targets.

Australian Unity Office Fund reports a $35.6 million loss for FY25 as it advances asset disposals ahead of planned delisting, with the final property sale facing settlement uncertainty.

Beam Communications reports a pivotal FY25 marked by the divestment of its Zoleo joint venture, unlocking significant capital and delivering improved margins despite a statutory revenue decline. The company projects positive operating cash flow and growth in FY26.

Cromwell Property Group reported a 15% drop in revenue and a 21% fall in operating profit for FY2025, yet significantly reduced its losses and net debt, signaling cautious progress amid challenging market conditions.

Shine Justice Ltd reported a revenue increase to $204.4 million in FY25 despite a dip in adjusted net profit after tax, driven by strategic restructuring and a sharpened focus on personal injury and international mass torts. The company is investing in technology and expanding its US footprint to fuel growth in FY26.

Westgold Resources Limited has announced an on-market buy-back of up to 47.18 million shares, signaling a strategic move to manage capital and potentially boost shareholder value.

Invion Limited has affirmed its compliance with ASX disclosure rules following the US FDA’s granting of Orphan Drug Designation for its anal cancer treatment candidate INV043. The company detailed the timing and verification process behind its announcement.

Pengana Capital Group Limited has reported a strong turnaround for FY2025, posting a $2.61 million profit after tax and a 42% increase in revenue to $60.5 million, driven by growth in private credit and performance fees.

Telix Pharmaceuticals has received a Complete Response Letter from the FDA for its TLX250-CDx diagnostic agent, citing manufacturing concerns. The company plans immediate remediation and maintains its 2025 revenue guidance.

GemLife Communities Group reported a 16% dip in net profit for H1 2025 but bolstered its balance sheet with a $750 million IPO and a strategic $220 million acquisition.

Eagers Automotive has reported a robust first half of 2025, with revenue climbing nearly 19% and net profit rising 8.8%, while maintaining its interim dividend at 24 cents per share.